Drug intelligence / Profile preview

BPL human rabies immune globulin

Development stage
Phase 3
Lead developer
Bio Products Laboratory
Modality
Recombinant Proteins and Enzymes
Administration
Intramuscular
01

Overview

BPL human rabies immune globulin (BPL HRIG) is a plasma-derived biologic developed by Bio Products Laboratory for rabies post-exposure prophylaxis. It consists of high-titer neutralizing antibodies (immunoglobulins) harvested from the plasma of human donors who have been immunized against the rabies virus. When administered following exposure to a rabid or suspected rabid animal, it provides immediate passive immunity by delivering pre-formed antibodies that neutralize the rabies virus at the site of entry, preventing its progression to the central nervous system. This product is typically used in conjunction with a rabies vaccine series to provide both immediate passive protection and long-term active immunity.

Other names
Human rabies immunoglobulinRabies immune globulin (human)BPL HRIG
02

Targets

RABV-G (Rabies virus glycoprotein)

Beyond the preview

Go deeper on BPL human rabies immune globulin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BPL human rabies immune globulin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call